Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Tracon Pharmaceuticals patents

List of Tracon Pharmaceuticals patents

List of Ekornes patents

List of BigML patents

List of SonicWall patents

List of companies in Mission BioCapital's investment portfolio

List of funding rounds for iRhythm Technologies

Patents where

Current Assignee

Name

is

Tracon Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9150652 Endoglin antibodies	Patent 9150652 was granted and assigned to Tracon Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	9150652	October 6, 2015
	‌ US Patent 10195281 Antibody formulations and uses thereof	Patent 10195281 was granted and assigned to Tracon Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	10195281	February 5, 2019
	‌ US Patent 9518122 Endoglin antibodies	Patent 9518122 was granted and assigned to Tracon Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	9518122	December 13, 2016
	‌ US Patent 9944714 Endoglin antibodies	Patent 9944714 was granted and assigned to Tracon Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	9944714	April 17, 2018
	‌ US Patent 10336831 Use of anti-endoglin antibodies for treating ocular fibrosis	Patent 10336831 was granted and assigned to Tracon Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	10336831	July 2, 2019
	‌ US Patent 10155820 Anti-endoglin antibodies and uses thereof	Patent 10155820 was granted and assigned to Tracon Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	10155820	December 18, 2018
	‌ US Patent 8017618 Antifolate agent combinations in the treatment of cancer	Patent 8017618 was granted and assigned to Tracon Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.		Tracon Pharmaceuticals		United States Patent and Trademark Office	8017618	September 13, 2011
	‌ US Patent 9926375 Anti-endoglin antibodies and uses thereof	Patent 9926375 was granted and assigned to Tracon Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office.	Tracon Pharmaceuticals	Tracon Pharmaceuticals		United States Patent and Trademark Office	9926375	March 27, 2018
	‌ US Patent 8221753 Endoglin antibodies	Patent 8221753 was granted and assigned to Tracon Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		Tracon Pharmaceuticals		United States Patent and Trademark Office	8221753	July 17, 2012
	‌ US Patent 8609094 Endoglin antibodies	Patent 8609094 was granted and assigned to Tracon Pharmaceuticals on December, 2013 by the United States Patent and Trademark Office.		Tracon Pharmaceuticals		United States Patent and Trademark Office	8609094	December 17, 2013

10 results

0 selected

10 results

0 selected